FDA Inspection

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)September 20, 2022

FDA Inspection 1181891 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - September 20, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), with an inspection on September 20, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
Inspection Date: September 20, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 33ac34b8-0200-4357-bc2a-e2425a7a2bad